![Maximum Statin Dosing - Adjustments in CKD Atorvastatin Lovastatin Pitavastatin Pravastatin Rosuvastatin Simvastatin Fluvastatin Simvastatin/ezetimibe doi: ... | GrepMed Maximum Statin Dosing - Adjustments in CKD Atorvastatin Lovastatin Pitavastatin Pravastatin Rosuvastatin Simvastatin Fluvastatin Simvastatin/ezetimibe doi: ... | GrepMed](https://img.grepmed.com/uploads/12278/dosing-statin-ckd-pharmacology-original.jpeg)
Maximum Statin Dosing - Adjustments in CKD Atorvastatin Lovastatin Pitavastatin Pravastatin Rosuvastatin Simvastatin Fluvastatin Simvastatin/ezetimibe doi: ... | GrepMed
![PDF] Therapeutic Interchange From Rosuvastatin to Atorvastatin in a Veteran Population. | Semantic Scholar PDF] Therapeutic Interchange From Rosuvastatin to Atorvastatin in a Veteran Population. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9ff3974d14236873c3c4c9b19ec78132c93d29ac/5-Table7-1.png)
PDF] Therapeutic Interchange From Rosuvastatin to Atorvastatin in a Veteran Population. | Semantic Scholar
![Understanding the Critical Disposition Pathways of Statins to Assess Drug–Drug Interaction Risk During Drug Development: It's Not Just About OATP1B1 - Elsby - 2012 - Clinical Pharmacology & Therapeutics - Wiley Online Library Understanding the Critical Disposition Pathways of Statins to Assess Drug–Drug Interaction Risk During Drug Development: It's Not Just About OATP1B1 - Elsby - 2012 - Clinical Pharmacology & Therapeutics - Wiley Online Library](https://ascpt.onlinelibrary.wiley.com/cms/asset/aa2970ac-bbb3-4bfb-8ab7-3effc778b0f3/cptclpt2012163-tbl-0001-m.jpg)
Understanding the Critical Disposition Pathways of Statins to Assess Drug–Drug Interaction Risk During Drug Development: It's Not Just About OATP1B1 - Elsby - 2012 - Clinical Pharmacology & Therapeutics - Wiley Online Library
![Conversion to Atorvastatin in Patients Intolerant or Refractory to Simvastatin Therapy: The CAPISH Study - Mayo Clinic Proceedings Conversion to Atorvastatin in Patients Intolerant or Refractory to Simvastatin Therapy: The CAPISH Study - Mayo Clinic Proceedings](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/73429/439439/si5.gif)
Conversion to Atorvastatin in Patients Intolerant or Refractory to Simvastatin Therapy: The CAPISH Study - Mayo Clinic Proceedings
![Quantitative evaluation of statin effectiveness versus intolerance and strategies for management of intolerance - Atherosclerosis Quantitative evaluation of statin effectiveness versus intolerance and strategies for management of intolerance - Atherosclerosis](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/09c13ffc-8fa9-4e51-b086-43974d8d031d/fx1.jpg)
Quantitative evaluation of statin effectiveness versus intolerance and strategies for management of intolerance - Atherosclerosis
![Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Recommendation Statement - U.S. Preventive Services Task Force - American Family Physician Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Recommendation Statement - U.S. Preventive Services Task Force - American Family Physician](https://www.aafp.org/afp/2017/0115/hi-res/afp20170115od1-t1.gif)
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Recommendation Statement - U.S. Preventive Services Task Force - American Family Physician
![Treatment Failure With Atorvastatin After Change From Rosuvastatin to Atorvastatin | Federal Practitioner Treatment Failure With Atorvastatin After Change From Rosuvastatin to Atorvastatin | Federal Practitioner](https://cdn.mdedge.com/files/s3fs-public/images/RTEmagicC_027_FP1215_T4.jpg.jpg)
Treatment Failure With Atorvastatin After Change From Rosuvastatin to Atorvastatin | Federal Practitioner
![PDF] Therapeutic Interchange From Rosuvastatin to Atorvastatin in a Veteran Population. | Semantic Scholar PDF] Therapeutic Interchange From Rosuvastatin to Atorvastatin in a Veteran Population. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9ff3974d14236873c3c4c9b19ec78132c93d29ac/2-Table2-1.png)